Positioning As-needed Budesonide–Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2

Rationale: The SYGMA (Symbicort Given as Needed in Mild Asthma) studies evaluated the efficacy and safety of as-needed budesonide (BUD)–formoterol (FORM) in patients whose asthma was uncontrolled on as-needed inhaled short-acting bronchodilators (subgroup 1) or controlled on inhaled corticosteroids...

Descripción completa

Detalles Bibliográficos
Autores principales: Bateman, Eric D., O’Byrne, Paul M., FitzGerald, J. Mark, Barnes, Peter J., Zheng, Jinping, Lamarca, Rosa, Puu, Margareta, Parikh, Himanshu, Alagappan, Vijay, Reddel, Helen K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750058/
https://www.ncbi.nlm.nih.gov/pubmed/33979557
http://dx.doi.org/10.1513/AnnalsATS.202011-1386OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750058/
https://www.ncbi.nlm.nih.gov/pubmed/33979557
http://dx.doi.org/10.1513/AnnalsATS.202011-1386OC

Ejemplares similares